If you manufacture or supply food contact materials for more than one market, you already know the frustrating truth: passing FDA review doesn't mean you're compliant in the EU, and EU compliance doesn't carry over to China. Each system evaluates safety differently, uses different documentation, and fails materials for different reasons.
This isn't a regulatory footnote. It's the single biggest reason multi-region product launches get delayed — not because the material is unsafe, but because a team optimized for one region's logic runs into another region's blind spot.
Here's how the three major systems actually compare, and where the real compliance risk sits in each one.
The Three Systems at a Glance
| United States (FDA) | European Union | China | |
|---|---|---|---|
| Core framework | 21 CFR Parts 170–199; FCN, GRAS, Prior Sanction, TOR pathways | Regulation (EU) 10/2011 (plastics) + Framework Regulation 1935/2004 | GB 4806 series + GB 9685 (additives) |
| Approval model | Positive list + notification/petition system | Positive list ("Union list") + mandatory self-declaration (DoC) | Positive list, material-specific GB standards |
| Who verifies compliance | FDA reviews FCN submissions; GRAS can be self-determined | Manufacturer self-declares via Declaration of Compliance | Manufacturer declares compliance against GB standard; DoC required |
| Primary technical risk | Migration/exposure thresholds, correct pathway selection | Overall migration limits, specific migration limits, NIAS assessment | Migration limits per material-specific GB standard, positive list matching |
| Recent regulatory activity | FSMA supplier verification expectations continue to tighten | Regulation (EU) 2026/245 (Feb 2026) expanded the authorized substances list; BPA rules under 2024/3190 tightened significantly | GB 4806.10-2025 (coatings) and GB 4806.16-2025 (silicone rubber) take effect September 2026, with BPA migration limits cut tenfold |
United States: A Pathway Problem, Not a Listing Problem
Most teams assume FDA compliance is about checking whether a substance appears on a list. In practice, the harder decision is choosing the right pathway — Food Contact Notification (FCN), GRAS, Prior Sanction, or Threshold of Regulation (TOR) exemption — and defending that choice if it's challenged.
Each pathway carries different assumptions about migration, different timelines, and different levels of regulatory scrutiny. Choosing the wrong one, or leaning on an exemption that doesn't actually apply to the use case, is one of the most common causes of late-stage compliance failures — often after testing is already complete.
See the full FDA compliance framework, including FCN vs. GRAS decision logic →
European Union: Self-Declaration Puts the Burden on You
Unlike the US notification model, the EU runs on self-declaration. There's no "EU approval" — manufacturers must produce a Declaration of Compliance (DoC) demonstrating that a material meets Regulation (EU) 10/2011 (for plastics) and the broader Framework Regulation 1935/2004.
The EU's positive list (the "Union list" in Annex I) is under continuous revision — Commission Regulation (EU) 2026/245, which entered into force in February 2026, added and revised authorizations for several substances used in polyolefins, polyamides, PET, PLA, and PVC materials. Bisphenol A rules have also tightened substantially under Regulation (EU) 2024/3190, with transitional provisions running through September 2026 for products already on the market.
The technical risk that trips up most non-EU manufacturers isn't the positive list itself — it's Non-Intentionally Added Substances (NIAS): breakdown products, impurities, and reaction by-products that aren't deliberately added but still have to be risk-assessed. NIAS evaluation is where "compliant on paper" and "compliant in practice" most often diverge.
China: Fast-Moving Standards, Material-Specific Rules
China's GB 4806 series governs food contact materials by material type — separate standards exist for plastics, coatings, rubber, silicone rubber, paper, adhesives, and more, each with its own positive list under GB 9685.
This system has moved quickly in the past two years. Revised standards for coatings (GB 4806.10-2025) and silicone rubber (GB 4806.16-2025) take effect September 2026, expanding the approved substance list for coatings from 105 to 346 entries and cutting the BPA specific migration limit tenfold, from 0.6 mg/kg to 0.05 mg/kg. A draft standard for food-contact regenerated cellulose materials was also opened for consultation in 2026.
For international manufacturers, the practical risk in China isn't unfamiliarity with the concept of a positive list — it's the pace of standard revisions and the requirement to track which GB standard version applies to a specific material category, since older versions are explicitly invalidated once revisions take effect.
Why This Matters for Multi-Region Launches
The teams that get burned aren't the ones who don't know the regulations exist — they're the ones who apply one region's compliance logic to another region's system. FDA's notification model, the EU's self-declaration burden, and China's material-specific GB standards each require a different verification approach, different documentation, and different technical justification.
Getting this right up front — before formulation is locked and before submission timelines are set — is what separates a smooth multi-region launch from a late-stage scramble.
Go Deeper
This overview is intentionally high-level. For a full, decision-focused breakdown of FDA compliance specifically — including FCN vs. GRAS vs. Prior Sanction decision criteria, migration and exposure assessment logic, and the functional barrier assumptions that most often fail under review — see the complete training:
Sources: European Commission Food Safety Directorate; UL Solutions; SGS Safeguards; knoell regulatory updates; SESEC; ChemLinked; Kelley Drye & Warren (KHLaw) regulatory analysis.
